机构:[1]Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China[2]Sichuan Univ, Chinese Cochrane Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China四川大学华西医院[3]Sichuan Univ, Chinese Evidence Based Med Ctr, Dept Clin Epidemiol, West China Hosp, Chengdu, Sichuan, Peoples R China四川大学华西医院[4]Beijing Univ Chinese Med, Key Lab Chinese Internal Med, Minist Educ & Beijing, Dongzhimen Hosp, Beijing, Peoples R China[5]Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England[6]Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
Chinese herbal medicine (CHM) formulas are the major components of traditional Chinese medicine (TCM) interventions. The general reporting quality of randomized controlled trials (RCTs) of CHM formulas is disappointing, although CONSORT (Consolidated Standards of Reporting Trials) Statement extensions for herbal medicinal interventions and acupuncture interventions are available. A group of TCM clinical experts, methodologists, epidemiologists, and editors has developed this CONSORT Extension for CHM Formulas (CONSORT-CHM Formulas 2017) through a comprehensive process, including publication of the draft version, solicitation of comments, revision, and finalization. The CONSORT 2010 Statement was extended by introducing the idea of TCM Pattern and the features of CHM formulas. One new checklist subitem, keywords, was added to facilitate indexing and data searching. Seven of the 25 CONSORT checklist items, namely title and abstract, background and objectives, participants, interventions, outcomes, generalizability, and interpretation, are now elaborated, and the explanation of harms specific to CHM formulas is revised. Illustrative examples and explanations are also provided. The group hopes that CONSORT-CHM Formulas 2017 can improve the reporting quality of RCTs of CHM formulas.
基金:
The development of CONSORT-CHM Formulas 2017 was funded in part from the Hong Kong HospitalAuthority, HKSAR (HA/09-10/01)
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|1 区医学
小类|1 区医学:内科
最新[2023]版:
大类|1 区医学
小类|1 区医学:内科
第一作者:
第一作者机构:[1]Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China
通讯作者:
通讯机构:[1]Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China[*1]Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China
推荐引用方式(GB/T 7714):
Cheng Chung-Wah,Wu Tai-Xiang,Shang Hong-Cai,et al.CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration[J].Annals Of Internal Medicine.2017,167(2):112-121.doi:10.7326/M16-2977.
APA:
Cheng Chung-Wah,Wu Tai-Xiang,Shang Hong-Cai,Li You-Ping,Altman Douglas G...&Bian Zhao-Xiang.(2017).CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.Annals Of Internal Medicine,167,(2)
MLA:
Cheng Chung-Wah,et al."CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration".Annals Of Internal Medicine 167..2(2017):112-121